Skip to main content
Innate Pharma logo

Innate Pharma — Investor Relations & Filings

Ticker · IPH ISIN · FR0010331421 LEI · 9695002Y8420ZB8HJE29 PA Manufacturing
Open in API
Filings indexed 1,409 across all filing types
Latest filing 2014-12-08 Earnings Release
Country FR France
Listing PA IPH

About Innate Pharma

http://www.innate-pharma.com/

Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.

Recent filings

Filing Released Lang Actions
CP resultats 3e trim
Earnings Release Classification · 95% confidence The document is a press release titled 'INFORMATION FINANCIERE DU TROISIEME TRIMESTRE 2014' (Financial Information for the Third Quarter 2014). It provides key financial highlights, including revenue and cash position for the nine-month period ending September 30, 2014, and includes a table of financial data. While it contains financial data, it is structured as an initial announcement of quarterly results (Earnings Release) rather than a full comprehensive interim report. Therefore, it fits the definition of an Earnings Release (ER). 9M 2014
2014-12-08 French
PR calendar 2015
Report Publication Announcement Classification · 99% confidence The document is titled "INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2015 AS WELL AS ITS PARTICIPATION IN UPCOMING INVESTOR CONFERENCES". It explicitly lists future dates for the publication of financial statements (2014 financial statements, 1Q2015 revenue, 3Q2015 revenue) and the Annual Shareholders Meeting. This document is an announcement about future corporate events and reporting schedules, not the reports themselves (like 10-K or IR). Since it announces the timing of report publications, it fits the definition of a Report Publication Announcement (RPA). It is too specific to be a general Regulatory Filing (RNS).
2014-12-08 English
calendrier financier
Report Publication Announcement Classification · 99% confidence The document is a press release from Innate Pharma dated December 2, 2014, announcing its financial calendar for 2015, including dates for the annual results, Q1 revenue, half-year results, and the Annual General Meeting (AGM). It also lists investor conferences the management will attend. Since the document's primary purpose is to announce future dates for financial reports and corporate events (like the AGM and investor meetings), and it is short (4447 characters), it fits the definition of a Report Publication Announcement (RPA) or a general announcement. Given the specific mention of the 'calendrier financier' and upcoming investor meetings, RPA is the most precise fit, as it announces the publication schedule of other reports (like the 2014 annual results and Q1 revenue). It is not the report itself (10-K or IR), nor is it the AGM material (AGM-R), but the announcement of the AGM date.
2014-12-08 French
financial calendar 2015
Report Publication Announcement Classification · 99% confidence The document is titled "INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2015 AS WELL AS ITS PARTICIPATION IN UPCOMING INVESTOR CONFERENCES". It explicitly lists future dates for the publication of financial statements (2014 financial statements, 1Q2015 revenue, 3Q2015 revenue) and the Annual Shareholders Meeting. This document is an announcement about future corporate events and reporting schedules, not the reports themselves (like 10-K or IR). Since it announces the timing of report publications, it fits the definition of a Report Publication Announcement (RPA). It is too specific to be a general Regulatory Filing (RNS).
2014-12-02 English
calendrier financier
Report Publication Announcement Classification · 99% confidence The document is a press release from Innate Pharma dated December 2, 2014, announcing its financial calendar for 2015, including dates for the annual results, Q1 revenue, half-year results, and the Annual General Meeting (AGM). It also lists investor conferences the management will attend. Since the document's primary purpose is to announce future dates for financial reports and corporate events (like the AGM and investor meetings), and it is short (4447 characters), it fits the definition of a Report Publication Announcement (RPA) or a general announcement. Given the specific mention of the 'calendrier financier' and upcoming investor meetings, RPA is the most precise fit, as it announces the publication schedule of other reports (like the 2014 annual results and Q1 revenue). It is not the report itself (10-K or IR), nor is it the AGM material (AGM-R), but the announcement of the AGM date.
2014-12-02 French
PUBLICATION DE DONNEES PRECLINIQUES DE IPH4102
Regulatory Filings Classification · 95% confidence The document is a press release dated November 3, 2014, announcing the publication of preclinical data for a drug candidate (IPH4102) in the scientific journal 'Cancer Research'. It details scientific findings, mentions regulatory status (orphan drug designation), and provides company/investor contact information. This type of announcement, which communicates significant scientific or operational news outside of mandatory periodic financial reports (like 10-K or IR), typically falls under general regulatory announcements or investor relations communications. Since it is not a formal financial report (10-K, IR, ER, MRQ), a specific management change (MANG), or a formal voting result (DVA), it best fits the general 'Regulatory Filings' (RNS) category, which serves as a broad category for non-standard, material announcements, or potentially an Investor Presentation (IP) if it were structured as a slide deck, but here it reads like a news release about external publication. Given the context of a press release announcing external scientific validation, RNS is the most appropriate general classification for a material, non-periodic update.
2014-11-03 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.